natgillin/translations-raw huggingface dataset:
The most common side effects with Tracleer (seen in 1 or more patients in 10) are headache, oedema (swelling) or fluid retention, anaemia (low levels of haemoglobin, the protein found in red blood cells that carries oxygen around the body) and abnormal results of tests carried out to check the liver.
Najčešće nuspojave lijeka Tracleer (mogu se javiti u više od 1 na 10 osoba) su glavobolja, edem (oticanje) ili zadržavanje tekućine, anemija (niske razine hemoglobina, proteina koji je prisutan u crvenim krvnim stanicama koje prenose kisik u tijelu) i abnormalni rezultati testova provedenih kako bi se provjerila jetra.
The most common side effects with Translarna (which may affect more than 1 in 10 people) are nausea (feeling sick), vomiting and headache.
Najčešće nuspojave lijeka Translarna (mogu se javiti u više od 1 na 10 osoba) su mučnina (osjećaj slabosti), povraćanje i glavobolja.
The most common side effects with Truvada (seen in more than 1 patient in 10) are hypophosphataemia (low levels of phosphates in the blood), headache, dizziness, diarrhoea, vomiting, nausea (feeling sick), rash, weakness and raised blood levels of creatine kinase (an enzyme found in muscles).
Najčešće nuspojave lijeka Truvada (zabilježene u više od 1 na 10 bolesnika) su hipofosfatemija (niske razine fosfata u krvi), glavobolja, omaglica, proljev, povraćanje, mučnina (osjećaj slabosti), osip, slabost i povećane razine kreatin kinaze u krvi (enzima koji se nalazi u mišićima).
The most common side effects with Tyverb (seen in more than 25% of patients) are rash and side effects affecting the stomach and gut (such as diarrhoea, nausea (feeling sick) and vomiting).
Najčešće nuspojave lijeka Tyverb (mogu se javiti u više od 25 % bolesnika) su osip i nuspojave koje zahvaćaju želudac i crijeva (poput proljeva, mučnine (osjećaja slabosti) i povraćanja).
The most common side effects with Uptravi (which may affect more than 1 in 10 people) are headache, diarrhoea, nausea and vomiting, jaw pain, myalgia (muscle pain), pain in the limbs, arthralgia (joint pain) and flushing.
Najčešće nuspojave lijeka Uptravi (mogu se javiti u više od 1 na 10 osoba) su glavobolja, proljev, mučnina i povraćanje, bol u čeljusti, mialgija (bol u mišićima), bol u ekstremitetima, artralgija (bol u zglobovima) i crvenilo.
The most common side effects with Valdoxan (seen in between 1 and 10 patients in 100) are headache, dizziness, somnolence (sleepiness), insomnia (difficulty sleeping), migraine, nausea (feeling sick), diarrhoea, constipation, abdominal pain (stomach ache), vomiting, hyperhidrosis (excessive sweating), back pain, fatigue (tiredness), increases in liver enzymes and anxiety.
Najčešće nuspojave lijeka Valdoxan (koje se mogu javiti u više od 1 na 10 osoba) su glavobolja, vrtoglavica, somnolencija (pospanost), nesanica (poteškoće u spavanju), migrena, mučnina (osjećaj slabosti), proljev, zatvor, abdominalna bol (bol u trbuhu), povraćanje, hiperhidroza (prekomjerno znojenje), bol u leđima, iscrpljenost (umor), povećanje u razinama enzima jetre i anksioznost.
The most common side effects with Vectibix (seen in more than 2 patients in 10) are diarrhoea, nausea (feeling sick), vomiting, constipation, abdominal pain (stomach ache), fatigue (tiredness), pyrexia (fever), lack of appetite, paronychia (nail bed infection), rash, acneiform dermatitis (skin inflammation resembling acne), pruritus (itching), erythema (reddening of the skin) and dry skin.
Najčešće nuspojave lijeka Vectibix (koje se mogu javiti u više od 2 na 10 osoba) su proljev, mučnina (osjećaj slabosti), povraćanje, zatvor, abdominalna bol (bol u trbuhu), iznimna iscrpljenost (umor), pireksija (vrućica), izostanak apetita, paronihija (infekcije tkiva oko noktiju na rukama i nogama), osip, akneiformni dermatitis (kožna upala koja sliči aknama), pruritus (svrbež), eritem (crvenilo kože) i suha koža.
The most common side effects with Viagra are headache, flushing, dyspepsia (indigestion), visual disorders, including visual colour distortion and blurred vision, nasal congestion (blocked nose), dizziness, nausea and hot flush.
Najčešće nuspojave povezane s lijekom Viagra su glavobolja, navala crvenila, dispepsija (loša probava), poremećaji vida, uključujući iskrivljavanje boja kod vida i zamućeni vid, nazalnu kongestiju (začepljen nos), omaglicu, mučninu i navale vrućine.
The most common side effects with Victoza (seen in more than 1 patient in 10) are nausea and diarrhoea.
Najčešće nuspojave lijeka Victoza (mogu se javiti u više od 1 na 10 bolesnika) su mučnina i proljev.
The most common side effects with Viekirax in combination with dasabuvir and ribavirin (which may affect more than 1 in 10 people) are insomnia (difficulty sleeping), nausea, pruritus (itching), asthenia (weakness) and fatigue (tiredness).
Najčešće nuspojave lijeka Viekirax (mogu se javiti u više od 1 na 10 osoba) su insomnija (poteškoće sa spavanjem), mučnina, pruritus (svrbež), astenija (slabost) i iscrpljenost (umor).
The most common side effects with Vimizim (which may affect more than 1 in 10 people) are infusion- related reactions, including headache, nausea (feeling sick), vomiting, fever, chills and abdominal pain (stomach ache).
Najčešće nuspojave lijeka Vimizim (kod više od 1 na 10 osoba) su reakcije povezane s infuzijom, uključujući glavobolju, mučninu (osjećaj slabosti), povraćanje, groznicu, drhtavicu i abdominalnu bol (bol u trbuhu).
The most common side effects with Viread (seen in more than 1 patient in 10) are nausea (feeling sick), vomiting, diarrhoea, dizziness, hypophosphataemia (low levels of phosphate in the blood), rash and asthenia (weakness).
Najčešće nuspojave s lijekom Viread (kod više od 1 na 10 osoba) su mučnina (osjećaj slabosti), povraćanje, proljev, vrtoglavica, hipofosfataemija (niske razine fosfata u krvi), osip i astenija (slabost).
The most common side effects with Volibris (seen in more than 1 patient in 10) are headache (including sinus headache and migraine), peripheral oedema (swelling, especially of the ankles and feet) and fluid retention.
Najčešće nuspojave lijeka Volibris (mogu se javiti u više od 1 na 10 bolesnika) jesu glavobolja (uključujući sinusnu glavobolju i migrenu), periferni edem (oticanje, najčešće gležnjeva i stopala) te zadržavanje tekućine.
The most common side effects with Votubia (seen in more than 1 in 10 patients) are acne, stomatitis (inflammation of the lining of the mouth), upper respiratory tract infections (colds), nasopharyngitis (inflammation of the nose and throat), sinusitis (inflammation of the sinuses), otitis media (infection of the middle ear), pneumonia (infection of the lung), increased blood levels of cholesterol, irregular menstruation (periods) and amenorrhoea (absence of periods).
Najčešće nuspojave pri primjeni lijeka Votubia (uočene u više od 1 na 10 osoba) su akne, stomatitis (upala sluznice usta), infekcije gornjih dišnih putova (prehlade), nazofaringitis (upala nosa i grla), sinusitis (upala sinusa), otitis media (upala srednjeg uha), pneumonija (upala pluća), povišena razina kolesterola u krvi, neredovite menstruacije i amenoreja (izostanak menstruacije).
The most common side effects with Xadago (which may affect up to 1 in 10 people) are insomnia (difficulty sleeping), dyskinesia (difficulty controlling movement), somnolence (sleepiness), dizziness, headache, worsening of existing Parkinson’s disease, cataract (clouding of the lens), orthostatic hypotension (drop in blood pressure when standing up), nausea (feeling sick) and falls.
Najčešće nuspojave lijeka Xadago (mogu se javiti u više od 1 na 10 osoba) su insomnija (poteškoće sa spavanjem), diskinezija (poteškoće s kontroliranjem pokreta), somnolencija (pospanost), omaglica, glavobolje, pogoršanje postojeće Parkinsonove bolesti, katarakt (magljenje leća), ortostatska hipotenzija (pad u krvnom tlaku prilikom stajanja), mučnina (osjećaj slabosti) i padovi.
The most common side effects with Xalkori (seen in more than 1 in 4 patients) are vision problems, nausea (feeling sick), diarrhoea, vomiting, oedema (swelling), increases in liver enzymes in the blood, decreased appetite, constipation, dizziness, neuropathy (pain due to nerve damage) and fatigue.
Najčešće nuspojave lijeka Xalkori (zabilježene u više od 1 na 4 osoba) su problemi s vidom, mučnina (osjećaj slabosti), proljev, povraćanje, edem (oticanje), povišenje koncentracije jetrenih enzima u krvi, smanjeni apetit, zatvor, vrtoglavica, neuropatija (bol uslijed oštećenja živaca) i umor.
The most common side effects with Xeloda (seen in more than 1 patient in 10) are anorexia (loss of appetite), diarrhoea, vomiting, nausea (feeling sick), stomatitis (sores in the mouth), abdominal (tummy) pain, palmar-plantar erythrodysaesthesia syndrome (‘hand-foot syndrome’, a skin reaction with rash and pain on the hands and feet), fatigue (tiredness) and asthenia (weakness).
Najčešće nuspojave lijeka Xeloda (mogu se javiti u više od 1 na 10 osoba) su anoreksija (gubitak apetita), proljev, povraćanje, mučnina (osjećaj slabosti), stomatitis (bolne rane u ustima), abdominalna bol (u želucu), sindrom palmarno-plantarne eritrodizaestezije ("sindrom ruku-nogu", reakcije kože s osipom i bolovima na rukama i stopalima), iscrpljenost (umor) i astenija (slabost).
The most common side effects with Xgeva (seen in more than 1 patient in 10) are dyspnoea (difficulty breathing), diarrhoea and pain in the muscles and bones.
Najčešće nuspojave lijeka Xgeva (mogu se javiti u više od 1 na 10 osoba) su dispneja (poteškoće u disanju), proljev i bol u mišićima i kostima.
The most common side effects with Xigduo (which may affect more than 1 in 10 people) are hypoglycaemia (when used together with insulin or a sulphonylurea) and gastrointestinal symptoms (symptoms affecting the stomach and gut).
Najčešće nuspojave lijeka Xigduo (kod više od 1 na 10 osoba) su hipoglikemija (ako se koristi zajedno s inzulinom ili sulfonilurejom) i gastrointestinalni simptomi (simptomi koji utječu na želudac i crijeva).
The most common side effects with Xofigo (which may affect more than 1 in 10 people) are diarrhoea, nausea (feeling sick), vomiting and thrombocytopenia (low blood-platelet counts).
Najčešće nuspojave lijeka Xofigo (koje se mogu javiti u više od 1 na 10 osoba) su proljev, mučnina (osjećaj slabosti), povraćanje i trombokitopenija (mali broj trombocita).
The most common side effects with Xtandi (which may affect more than 1 in 10 people) are tiredness, headache, hot flushes and hypertension (high blood pressure).
Najčešće nuspojave lijeka (koje se mogu javiti u više od 1 na 10 osoba) su umor, glavobolja, navala vrućine i hipertenzija (visoki krvni tlak).
The most common side effects with ZACTRAN in cattle (which may affect more than 1 in 10 cattle) are swellings at the site of injection.
Najčešće nuspojave VMP-a ZACTRAN (mogu se javiti u više od 1 na 10 goveda) su otekline na mjestu injekcije.
The most common side effects with ZACTRAN in pigs (which may affect up to 1 in 10 pigs) are mild to moderate swellings at the site of injection.
Najčešće nuspojave VMP-a ZACTRAN u svinja (mogu se javiti u do 1 na 10 svinja) blage su do umjerene otekline na mjestu injekcije.
The most common side effects with Zerbaxa (which may affect up to 1 in 10 people) are nausea (feeling sick), headache, constipation, diarrhoea and fever, which are generally mild or moderate.
Najčešće nuspojave lijeka Zerbaxa (koje su uočene u 1 na 10 bolesnika) su mučnina (osjećaj slabosti), glavobolja, zatvor, proljev i vrućica, a koje su načelno bile blage ili umjerene.
The most common side effects with Zinforo (seen in more than 3% of patients) are diarrhoea, headache, nausea (feeling sick), and pruritus (itching), which were generally mild or moderate in severity.
Najčešće nuspojave lijeka Zinforo (zabilježene u više od 3 % bolesnika) jesu proljev, glavobolja, mučnina (osjećaj slabosti) i pruritus (svrbež), koji su uglavnom bili blagog ili umjerenog intenziteta.
The most common side effects with Zydelig (which may affect more than 1 in 10 people) are infections (including lung infection caused by Pneumocystis jirovecii, and cytomegalovirus infections), neutropenia (low levels of neutrophils, a type of white blood cell), diarrhoea, increased liver enzymes in blood, rash, fever and increased blood fat levels.
Najčešće nuspojave lijeka Zydelig (mogu se javiti u više od 1 na 10 osoba) su infekcije (uključujući plućnu infekciju koju uzrokuje gljivica Pneumocystis jirovecii i citomegalovirusne infekcije), neutropenija (niske razine neutrofila, tipa bijelih krvnih stanica), proljev, povišeni jetreni enzimi u krvi, osip, groznica i povišene razine masti u krvi.
The most common side effects with Zykadia (which may affect 1 or more people in 10) are diarrhoea, nausea (feeling sick), vomiting, tiredness, abnormal liver tests, abdominal pain (stomach ache), decreased appetite, constipation, rash, increases in the level of a waste product called creatinine in the blood (a possible sign of kidney problems), oesophageal disorder (problems affecting the gullet between mouth and stomach) and anaemia (low levels of red blood cells).
Najčešće nuspojave lijeka Zykadia (koje se mogu javiti u 1 ili više osoba na 10) su proljev, mučnina, povraćanje, umor, abnormalni jetreni testovi, abdominalna bol (bol u trbuhu), smanjeni apetit, zatvor, osip, povišene razine otpadnog proizvoda naziva kreatinin u krvi (mogući znak problema s bubrezima), ezofagealni poremećaj (problemi koji zahvaćaju ždrijelo između usta i želuca) i anemija (mali broj crvenih krvnih stanica).
The most common site of spontaneous bleeding was the gastrointestinal tract (1.7% rate with prasugrel and 1.3% rate with clopidogrel); the most frequent site of provoked bleeding was the arterial puncture site (1.3% rate with prasugrel and 1.2% with clopidogrel).
Najčešće mjesto spontanog krvarenja bio je gastrointestinalni trakt (stopa od 1,7% kod primjene prasugrela i stopa od 1,3% kod primjene klopidogrela), a najčešće mjesto izazvanog krvarenja je mjesto punkcije arterije (1,3% stopa kod primjene prasugrela i 1,2% stopa kod primjene klopidogrela).
The most common symptoms have been rigors, headache, nausea, pyrexia, flushing and fatigue.
Najčešći simptomi bili su tresavica, glavobolja, mučnina, pireksija, crvenilo uz osjećaj vrućine i umor.
The most common symptoms of an infusion reaction included fever, chills, and hypertension.
Najčešći simptomi reakcije na infuziju uključivali su vrućicu, zimicu i hipertenziju.
The most common symptoms of IRs (occurring in ≥ 10% of patients treated with Vimizim and ≥ 5% more when compared to placebo) were headache, nausea, vomiting, pyrexia, chills and abdominal pain.
≥ 10% ispitanika liječenih Vimizimom i ≥ 5% više u usporedbi s placebom) bili su glavobolja, mučnina, povraćanje, pireksija, zimica i bolovi u trbuhu.
The most common symptoms of overdose with Siklos are:
Najčešći simptomi predoziranja Siklosom su sljedeći:
The most common symptoms of telmisartan overdose are low blood pressure (hypotension) and fast heart beat (tachycardia).
Najčešći simptomi predoziranja telmisartanom su sniženi krvni tlak (hipotenzija) i ubrzan rad srca (tahikardija).
The most common symptoms that may occur after if you use more BiResp Spiromax than you should are trembling, headache or a rapid heartbeat.
Najčešći simptomi koji se mogu pojaviti ako koristite veću količinu lijeka BiResp Spiromax nego biste trebali su drhtanje, glavobolja ili brzi otkucaji srca.
The most common symptoms that may occur after if you use more BiResp Spiromax than you should are trembling, headache or a rapid heartbeat.
Najčešći simptomi koji se mogu pojaviti, ako koristite veću količinu lijeka BiResp Spiromax nego biste trebali, su drhtanje, glavobolja ili brzi otkucaji srca.
The most common symptoms that may occur after if you use more Budesonide/Formoterol Teva than you should are trembling, headache or a rapid heartbeat.
Najčešći simptomi koji se mogu pojaviti ako koristite veću količinu lijeka Budezonid/Formoterol Teva nego biste trebali su drhtanje, glavobolja ili brzi otkucaji srca.
The most common symptoms that may occur after if you use more Budesonide/Formoterol Teva than you should are trembling, headache or a rapid heartbeat.
Najčešći simptomi koji se mogu pojaviti, ako koristite veću količinu lijeka Budezonid/Formoterol Teva nego biste trebali, su drhtanje, glavobolja ili brzi otkucaji srca.
The most common symptoms that may occur after if you use more DuoResp Spiromax than you should are trembling, headache or a rapid heartbeat.
Najčešći simptomi koji se mogu pojaviti ako koristite veću količinu lijeka DuoResp Spiromax nego biste trebali su drhtanje, glavobolja ili brzi otkucaji srca.
The most common symptoms that may occur after if you use more DuoResp Spiromax than you should are trembling, headache or a rapid heartbeat.
Najčešći simptomi koji se mogu pojaviti, ako koristite veću količinu lijeka DuoResp Spiromax nego biste trebali, su drhtanje, glavobolja ili brzi otkucaji srca.
The most common treatment-emergent adverse reactions reported in clinical studies with adult epileptic patients, both in placebo and eslicarbazepine acetate groups were dizziness, somnolence, headache, and nausea.
Najčešće prijavljene nuspojave povezane s liječenjem tijekom kliničkih ispitivanja odraslih bolesnika s epilepsijom, kako u skupinama koje su primale placebo tako i u skupinama koje su primale eslikarbazepinacetat, bile su omaglica, somnolencija, glavobolja i mučnina.
The most common, (may affect up to 1 in 10 people) serious side effect of treatment with Angiox, is major bleeding which could occur anywhere inside the body (e.g. stomach, digestive system (including vomiting blood or passing blood with the stools), abdomen, lungs, groin, bladder, heart, eye, ear, nose or brain).
Najčešća, (može zahvatiti do 1 na 10 osoba) ozbiljna nuspojava u liječenju Angioxom je veliko krvarenje koje se može javiti na bilo kojem mjestu u tijelu (primjerice u želucu, probavnom sustavu (uključujući povraćanje krvi ili izlučivanje krvi sa stolicom),trbuhu, plućima, preponama, mjehuru, srcu, oku, uhu, nosu ili mozgu)..
The most commonly (≥ 5 %) reported adverse drug reactions in patients with another indication treated with pramipexole were nausea, headache, dizziness and fatigue.
Najčešće (≥5%) prijavljene nuspojave u bolesnika s drugim indikacijama, u liječenju pramipeksolom bile su mučnina, glavobolja, omaglica i umor.
The most commonly (≥ 5 %) reported adverse drug reactions in patients with Parkinson’s disease more frequent with pramipexole treatment than with placebo were nausea, dyskinesia, hypotension, dizziness, somnolence, insomnia, constipation, hallucination, headache and fatigue.
Najčešće (≥5%) prijavljene nuspojave u bolesnika s Parkinsonovom bolešću, češće kod liječenja pramipeksolom nego placebom, bile su mučnina, diskinezija, hipotenzija, omaglica, somnolencija, nesanica, konstipacija, halucinacija, glavobolja i umor.
The most commonly (≥ 5%) reported adverse drug reactions in patients with other indication treated with pramipexole were nausea, headache, dizziness and fatigue.
Najčešće (≥ 5%) prijavljene nuspojave u bolesnika s drugom indikacijom, u liječenju pramipeksolom bile su mučnina, glavobolja, omaglica i umor.
The most commonly (≥ 5%) reported adverse drug reactions in patients with Parkinson’s disease more frequent with pramipexole treatment than with placebo were nausea, dyskinesia, hypotension, dizziness, somnolence, insomnia, constipation, hallucination, headache and fatigue.
Najčešće (≥5%) prijavljene nuspojave u bolesnika s Parkinsonovom bolešću, češće kod liječenja pramipeksolom nego placebom, bile su mučnina, diskinezija, hipotenzija, omaglica, somnolencija, nesanica, konstipacija, halucinacija, glavobolja i umor.
The most commonly (≥ 5%) reported adverse drug reactions in patients with Restless Legs Syndrome treated with pramipexole were nausea, headache, dizziness and fatigue.
Najčešće (≥5%) prijavljene nuspojave u bolesnika sa sindromom nemirnih nogu, u liječenju pramipeksolom bile su mučnina, glavobolja, omaglica i umor.
The most commonly (≥10%) occurring adverse reactions in all grades were anaemia (97.3%), leukopenia (95.7%), neutropenia (93.5%), thrombocytopenia (47.4%), and diarrhoea (46.6%).
Najčešće prijavljene nuspojave (≥ 10%) svih stupnjeva težine bile su anemija (97,3%), leukopenija (95,7%), neutropenija (93,5%), trombocitopenija (47,4%) i proljev (46,6%).
The most commonly (≥5%) occurring grade ≥3 adverse reactions in the cabazitaxel group were neutropenia (81.7%), leukopenia (68.2%), anaemia (10.5%), febrile neutropenia (7.5%), diarrhoea (6.2%).
Najčešće nuspojave stupnja ≥ 3 u skupini koja je primala kabazitaksel bile su neutropenija (81,7%), leukopenija (68,2%), anemija (10,5%), febrilna neutropenija (7,5%) i proljev (6,2%).
The most commonly (≥5%) reported adverse reactions in patients with Parkinson’s disease more frequent with pramipexole treatment than with placebo were nausea, dyskinesia, hypotension, dizziness, somnolence, insomnia, constipation, hallucination, headache and fatigue.
Najčešće (≥5%) prijavljene nuspojave u bolesnika s Parkinsonovom bolešću, češće kod liječenja pramipeksolom nego placebom, bile su mučnina, diskinezija, hipotenzija, omaglica, somnolencija, nesanica, konstipacija, halucinacija, glavobolja i umor.
The most commonly observed adverse reaction associated with the use of Bronchitol during the initiation dose assessment is cough (3.6% of patients), (see section 4.4).
Najčešća zabilježena nuspojava povezana s primjenom Bronchitola tijekom procjene početne doze je kašalj (3,6% pacijenata) (vidjeti dio 4.4).
The most commonly observed adverse reaction associated with the use of Bronchitol is cough.
Najčešća zabilježena nuspojava povezana s uporabom Bronchitola je kašalj.
The most commonly observed adverse reaction associated with the use of Tasmar, occurring more frequently than in placebo-treated patients are listed in the table below.
Najčešće opažene nuspojave povezane s primjenom Tasmara koje su se javljale češće nego u bolesnika koji su primali placebo navedene su u tablici ispod.
The most commonly observed adverse reactions which occurred more frequently in the lenalidomide groups compared to the control arm in the Phase III study were neutropenia (76.8%), thrombocytopenia (46.4%), diarrhoea (34.8%), constipation (19.6%), nausea (19.6%), pruritus (25.4%), rash (18.1%), fatigue (18.1%) and muscle spasms (16.7%).
U ispitivanju faze III najčešće opažene nuspojave, učestalije u skupinama koje su primale lenalidomid u usporedbi s kontrolnom skupinom, bile su: neutropenija (76.8%), trombocitopenija (46.4%), proljev (34,8%), konstipacija (19,6%), mučnina (19,6%), pruritus (25,4%), osip (18,1%), umor (18,1%) i mišićni spazam (16,7%).
The most commonly observed resistance- associated mutations that emerged included L100I, K101E, V108I, E138K, V179F, Y181C, H221Y, F227C and M230I.
Najčešće primijećene mutacije povezane s rezistencijom koje su se pojavile uključivale su L100I, K101E, V108I, E138K, V179F, Y181C, H221Y, F227C i M230I.
The most commonly occurring adverse reactions (≥ 20%) were diarrhoea, neutropenia, haemorrhage (e.g., bruising), musculoskeletal pain, nausea, rash, and pyrexia.
Nuspojave koje se najčešće javljale (≥ 20%) bile su proljev, neutropenija, krvarenje (npr. modrice), mišićno-koštana bol, mučnina, osip i pireksija.
The most commonly reported (≥ 10 %) treatment-related adverse reactions were mild nausea, vomiting, diarrhoea, abdominal pain, fatigue, myalgia, muscle cramps and rash.
Najčešće zabilježene nuspojave (10 %) povezane s liječenjem, bile su blaga mučnina, povraćanje, proljev, bol u trbuhu, umor, bol u mišićima, grčevi u mišićima i osip.
The most commonly reported (≥ 10%) drug-related adverse reactions in both settings were mild nausea, vomiting, diarrhoea, abdominal pain, fatigue, myalgia, muscle cramps and rash.
Najčešće zabilježene nuspojave (10%) koje su povezane s primjenom lijeka, bile su u obje situacije blaga mučnina, povraćanje, proljev, bol u trbuhu, umor, bol u mišićima, grčevi u mišićima i osip.